For Medical Institutions Struggling with Medical DX Reimbursement: AIBTRUST Launches 'Medical AI / DX Consulting Business' in June 2026, Providing End-to-End Support for Data Preparation, Legal Arrangements, and Tool Implementation
Key facts
- For Medical Institutions Struggling with Medical DX Reimbursement: AIBTRUST Launches 'Medical AI / DX Consulting Business' in June 2026, Providing End-to-End Support for Data Preparation, Legal Arrangements, and Tool Implementation
- AIBTRUST Co., Ltd. will launch its 'Medical AI / DX Consulting Business' for medical institutions in June 2026, offering end-to-end support for data preparation, legal arrangements, and tool implementation. This service aims to solve the challenges faced by medical institutions dealing with medical DX reimbursement requirements.
- Source: PR Times
- Date: June 4, 2026
Direct answer
AIBTRUST Co., Ltd. will launch its 'Medical AI / DX Consulting Business' for medical institutions in June 2026, offering end-to-end support for data preparation, legal arrangements, and tool implementation. This service aims to solve the challenges faced by medical institutions dealing with medical DX reimbursement requirements.
- Citation
- For Medical Institutions Struggling with Medical DX Reimbursement: AIBTRUST Launches 'Medical AI / DX Consulting Business' in June 2026, Providing End-to-End Support for Data Preparation, Legal Arrangements, and Tool Implementation (June 4, 2026), PR Times
- Source
- PR Times
- Date
- June 4, 2026
AIBTRUST Co., Ltd. will launch its 'Medical AI / DX Consulting Business' for medical institutions in June 2026, offering end-to-end support for data preparation, legal arrangements, and tool implementation. This service aims to solve the challenges faced by medical institutions dealing with medical DX reimbursement requirements.
📋 Article Processing Timeline
- 📰 Published: June 4, 2026 at 10:00
- 🔍 Collected: June 4, 2026 at 10:41 (41 min after Published)
- 🤖 AI Analyzed: June 6, 2026 at 23:34 (60h 52m after Collected)
As a fundamental solution to medical DX that cannot be achieved by simply introducing electronic medical records, AIBTRUST Co., Ltd. (Headquarters: Kita-ku, Osaka City) will launch the 'Medical AI / DX Consulting Business' for medical institutions in June 2026.
■ Background: The 'Invisible Risks' of Medical DX are Expanding
While the adoption of electronic medical records and generative AI is progressing, the following issues are becoming apparent in medical settings:
・Unprepared data: Abbreviations and documentation rules vary by doctor, preventing AI from functioning correctly.
・Legal risks: Issues to be sorted out before tool implementation, such as the Personal Information Protection Law, MIC guidelines, and third-party provision consent, are becoming more complex.
・System response: The 2026 medical fee revision will introduce a new 'Electronic Medical Information Collaboration System Development Surcharge (formerly Medical DX Promotion System Development Surcharge)', with stricter calculation requirements such as My Number Insurance Card usage rates and electronic prescription compatibility.
Many cases fail when trying to respond only by introducing tools. Based on the belief that 'the essence of medical DX lies in the development of a data infrastructure,' AIBTRUST is launching this consulting business.
■ Service Overview: One-Stop Support in Five Areas
01. DX Diagnosis and Current State Survey
Inventory hospital data, operational workflows, and existing systems to visualize bottlenecks and priorities.
02. Data/Manual Preparation
Support standardization of terms, abbreviations, and documentation rules, code mapping such as FHIR, and AI conversion of hospital manuals.
03. Legal and Security Arrangements
Comprehensively organize the Personal Information Protection Law, MIC guidelines, dynamic consent design, BAA contracts, and implementation policies for tools like AWS Bedrock.
04. Tool Selection and Implementation Support
Propose and implement the optimal tool configuration based on the hospital's operational and legal requirements.
05. Operational Support and Effect Measurement
Provide continuous support through phased deployment, KPI design, and adoption assistance.
■ How to Proceed: Start with a Free Consultation
STEP 01 Free Consultation (Online, 60 minutes)
STEP 02 Current State Survey and Issue Identification
STEP 03 Proposal and Quotation
STEP 04 Phased Implementation Support
■ Reasons to Choose AIBTRUST
・Expertise in medical settings through collaboration with Osaka University Hospital
・Design compliant with the Personal Information Protection Law and MIC guidelines
・End-to-end support system spanning AI, data, legal, and infrastructure
■ Launch Date and Application
Launching in June 2026
Apply for a free consultation here: https://www.aibtrust.jp/dx-consulting
■ Company Overview
Company Name: AIBTRUST Co., Ltd.
Representative: Representative Director Koichi Morioka
Headquarters: Kita-ku, Osaka City
Established: December 2023
Business: Medical AI/DX Consulting Business, Medical DX Solutions Business, Next-Generation Medical Registry Platform Business
URL: https://www.aibtrust.jp
■ Contact for Inquiries
AIBTRUST Co., Ltd.
Inquiry Form: https://www.aibtrust.jp/companycontact
■ Background: The 'Invisible Risks' of Medical DX are Expanding
While the adoption of electronic medical records and generative AI is progressing, the following issues are becoming apparent in medical settings:
・Unprepared data: Abbreviations and documentation rules vary by doctor, preventing AI from functioning correctly.
・Legal risks: Issues to be sorted out before tool implementation, such as the Personal Information Protection Law, MIC guidelines, and third-party provision consent, are becoming more complex.
・System response: The 2026 medical fee revision will introduce a new 'Electronic Medical Information Collaboration System Development Surcharge (formerly Medical DX Promotion System Development Surcharge)', with stricter calculation requirements such as My Number Insurance Card usage rates and electronic prescription compatibility.
Many cases fail when trying to respond only by introducing tools. Based on the belief that 'the essence of medical DX lies in the development of a data infrastructure,' AIBTRUST is launching this consulting business.
■ Service Overview: One-Stop Support in Five Areas
01. DX Diagnosis and Current State Survey
Inventory hospital data, operational workflows, and existing systems to visualize bottlenecks and priorities.
02. Data/Manual Preparation
Support standardization of terms, abbreviations, and documentation rules, code mapping such as FHIR, and AI conversion of hospital manuals.
03. Legal and Security Arrangements
Comprehensively organize the Personal Information Protection Law, MIC guidelines, dynamic consent design, BAA contracts, and implementation policies for tools like AWS Bedrock.
04. Tool Selection and Implementation Support
Propose and implement the optimal tool configuration based on the hospital's operational and legal requirements.
05. Operational Support and Effect Measurement
Provide continuous support through phased deployment, KPI design, and adoption assistance.
■ How to Proceed: Start with a Free Consultation
STEP 01 Free Consultation (Online, 60 minutes)
STEP 02 Current State Survey and Issue Identification
STEP 03 Proposal and Quotation
STEP 04 Phased Implementation Support
■ Reasons to Choose AIBTRUST
・Expertise in medical settings through collaboration with Osaka University Hospital
・Design compliant with the Personal Information Protection Law and MIC guidelines
・End-to-end support system spanning AI, data, legal, and infrastructure
■ Launch Date and Application
Launching in June 2026
Apply for a free consultation here: https://www.aibtrust.jp/dx-consulting
■ Company Overview
Company Name: AIBTRUST Co., Ltd.
Representative: Representative Director Koichi Morioka
Headquarters: Kita-ku, Osaka City
Established: December 2023
Business: Medical AI/DX Consulting Business, Medical DX Solutions Business, Next-Generation Medical Registry Platform Business
URL: https://www.aibtrust.jp
■ Contact for Inquiries
AIBTRUST Co., Ltd.
Inquiry Form: https://www.aibtrust.jp/companycontact
FAQ
When will this service be launched?
It is scheduled to launch in June 2026.
What types of medical institutions are targeted?
Medical institutions facing challenges with medical DX surcharge compliance, data preparation, and legal arrangements.
What are the main support areas of this service?
It provides one-stop support in five areas: DX diagnosis, data preparation, legal arrangement, tool selection/implementation, and operational follow-up.